The following adverse reactions have been observed for human albumin solutions during the postmarketing phase and can therefore also be expected for Albunorm 5% and Albunorm 20%. (See table.)
Click on icon to see table/diagram/image
For safety with respect to transmissible agents, see Precautions.
View ADR Monitoring Form